Henan Lingrui Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥12.20 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	17.93
Forward PE	14.83
Price to Sales TTM	CN¥3.42
Price to Book MRQ	CN¥4.22
Enterprise to Revenue	3.14
Enterprise to EBITDA	14.25

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	18.96%
Operating Margin	21.00%
Return on Assets TTM	9.31%
Return on Equity TTM	24.05%

Income Statement

Revenue TTM	CN¥3,563,808,000
Revenue per Share TTM	CN¥6.36
Quarterly Revenue Growth	5.80%
Gross Profit TTM	CN¥2,621,609,216
EBITDA	CN¥796,605,395
Net Income to Common TTM	CN¥675,800,384
Diluted EPS TTM	CN¥1.20
Quarterly Earnings Growth YoY	7.80%

Balance Sheet

Total Cash MRQ	CN¥956,811,456
Total Cash per Share MRQ	CN¥1.69
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	0.73
Current Ratio MRQ	1.18
Book Value per Share MRQ	CN¥5.10

Cash Flow

Operating Cash Flow TTM	CN¥654,789,056
Levered Free Cash Flow TTM	CN¥522,267,744

600285 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	567,115,008
Float Shares	436,474,763
Avg 10 Volume	5,803,061
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	22.88%
% Held by Institutions	24.98%

Stock Price Summary

Beta	0.34
Fifty Two Week Low	CN¥16.35
Fifty Two Week High	CN¥27.26
Fifty Two Week Change	17.29%
Day 50 MA	CN¥21.71
Day 200 MA	CN¥23.13

Dividends and Splits

Forward Annual Dividend Rate	CN¥3.20
Forward Annual Dividend Yield	14.88%
Trailing Annual Dividend Rate	CN¥0.80
Trailing Annual Dividend Yield	3.72%
Payout Ratio	66.45%
Dividend Date
Ex Dividend Date	2024-06-20
Last Split Factor
Last Split Date	2014-07-02